ROLE OF MODIFIABLE FACTORS IN THE DEVELOPMENT OF DIFFICULT TO CORRECT ARTERIAL HYPERTENSION IN CHRONIC RENAL FAILURE
https://doi.org/10.24884/1561-6274-2004-8-3-42-47
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
THE AIM of the investigation was to assess the role of modifiable factors in the development of stability of arterial hypertension (AH) in relation to hypotensive therapy as a whole and to therapy with loop diuretics in patients with chronic renal failure (CRF). PATIENTS AND METHODS. Under examination there were 103 patients with CRF and secondary AH. In 42 patients AH could be easily corrected by standard hypotensive therapy. In 61 patients AH failed to be corrected, so in order to normalize arterial pressure these patients received injections of furosemid in dose of 80 mg (120 mg at GFR<30 ml/min) in addition to their treatment. In these patients an assessment was made of the influence on the development of AH of such factors as age, gender, character of therapy received by the patients from the moment of diagnosis of the disease, keeping the regimen of treatment by the patient. RESULTS. Patients limiting consumption of salt could more easily reach normal arterial pressure both against the background of usual hypotensive therapy (χ2= 10.38; p<0.001) and under effects of furosemid (χ2=9.35; p<0.004), than patients taking salt ad libitum. Excessive consumption of water also facilitated the development of stable AH (χ2 =5.86; p<0.02). Indirect findings were obtained concerning the ability of the angiotensinconverting enzyme inhibitors to prevent the development of stable AH. Inconstant taking of hypotensive drugs facilitated the formation of stable hypertension (χ2 =5.19; p<0.02). CONCLUSION. The development of difficult to correct AH in pathology of the kidneys depends on many external modifiable factors that proves the significant role of the patients and doctors in prevention of progression of AH.
About the Authors
N. V. FetisovaRussian Federation
B. G. Lukichev
Russian Federation
References
1. Lavil' M. Rol' arterial'noi gipertonii v progressirovanii pochechnoi nedostatochnosti, effektivnost' antigipertenzivnoi terapii. Nefrologiya 2000; 4 (1): 119 123
2. Perneger TV, Whelton PK, Klag MJ. History of hypertension in patients treated for endstage renal disease. J Hypertens 1997; 15 (4): 451456
3. Kutyrina IM. Sovremennye aspekty patogeneza pochechnoi arterial'noi gipertenzii. Nefrologiya 2000; 4 (1): 112115
4. Appel LJ. Lifestyle modification as a means to prevent and treat high blood pressure. J Am Soc Nephrol 2003; 14 (7) [Suppl 2]: S99S102
5. Flack JM, Peters R, Shafi T, Alrefai H et al. Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. J Am Soc Nephrol 2003; 14 (7) [Suppl 2]: S928
6. Shanar Zh. Gipertoniya, sol' i pochki. Nefrologiya 2000; 4 (1): 98100
7. Shestakova MV. Nefroprotektsiya: rol' arterial'nogo davleniya v progressirovanii patologii pochek. Zavisit li nefroprotektivnyi effekt ot vybora antigipertenzivnogo preparata? Ter arkhiv 2001; 6: 6466
8. Petersen LJ, Ladefoged SD, Jensen HA. The influence of antihypertensive treatment on progression of chronic nephropathy. Ugeskr Laeger 1997; 159 (31): 47454751
9. Schwenger V, Zeier M, Ritz E. Antihypertensive therapy in renal patients - Benefits and difficulties. Nephron 1999; 83 (3): 202213
10. MartinezMaldonado M. Role of hypertension in the progression of chronic renal disease. Nephrol Dial Transplant 2001; 16: 6366
11. Ljutic D, Kes P. The role of arterial hypertension in the progression of nondiabetic glomerular diseases. Nephrol Dial Transplant 2003; 18 [Suppl 5]: v2830
12. Ridao N, Luno J, Garsia de Vinuesa S et al. Prevalence of hypertension in renal disease. Nephrol Dial Transplant 2001; 16: 7073
13. Bakris GL. Hypertension and nephropathy. Am J Med 2003; 8 (115) [Suppl 8A]: 49S54S.
Review
For citations:
Fetisova N.V., Lukichev B.G. ROLE OF MODIFIABLE FACTORS IN THE DEVELOPMENT OF DIFFICULT TO CORRECT ARTERIAL HYPERTENSION IN CHRONIC RENAL FAILURE. Nephrology (Saint-Petersburg). 2004;8(3):42-47. (In Russ.) https://doi.org/10.24884/1561-6274-2004-8-3-42-47
ISSN 2541-9439 (Online)